massdevice.com
October marks Breast Cancer Awareness Month, an annual focus on prevention, early detection and advances in treatment. Breast cancer is the second most common cancer among women in the United States after skin cancer. It remains a leading cause of cancer deaths, according to the National Cancer Institute. The American Cancer Society estimates that one […]
about 1 year ago
massdevice.com
AorticLab received FDA approval for an Investigational Device Exemption to begin a pivotal clinical trial of its FLOWer System in the U.S.
about 1 year ago
massdevice.com
Medtronic recently announced it has completed a €1.5 billion ($1.76 billion) public offering.
about 1 year ago
massdevice.com
Medtronic today announced the full U.S. rollout of the Neuroguard IEP system, a carotid stent and embolic protection device.
about 1 year ago
massdevice.com
Zimmer Biomet completed the acquisition of Monogram Technologies, an AI-driven orthopedic robotics company developing semi- and fully autonomous surgical systems.
about 1 year ago
massdevice.com
Vektor Medical today announced it received CE mark approval for its vMap artificial intelligence-powered arrhythmia mapping system.
about 1 year ago
massdevice.com
Philips today announced the 5,000th global installation of its Zenition mobile C-arm system at Kolín Regional Hospital in the Czech Republic.
about 1 year ago
massdevice.com
Remedy Robotics entered a strategic partnership with the Australian Stroke Alliance to bring its remotely operated cardiovascular intervention robot to hospitals across Australia.
about 1 year ago
massdevice.com
Johnson & Johnson MedTech CEO Tim Schmid said the company is entering its next phase of growth with a sharper focus on surgical robotics, cardiovascular technologies and targeted portfolio management.
about 1 year ago
massdevice.com
Globus Medical launched the Anthem Elbow Fracture System, a plating system designed to help surgeons manage a wide range of elbow fractures with simplified workflow and flexible fixation options.
about 1 year ago
massdevice.com
NextBiomedical enrolled the first patient in its U.S. pivotal clinical trial evaluating its Nexsphere-F, a fast-resorbable microsphere.
about 1 year ago
